NCT00255983View on ClinicalTrials.gov

A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis

PHASE3TerminatedINTERVENTIONAL

Enrollment

491

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

June 30, 2008

Conditions

Chronic Bronchitis

Interventions

DRUG

Faropenem medoxomil

600 mg BID for 5 days

DRUG

placebo

placebo tablets BID for 5 days

Trial Locations (1)

18938

Multicenter, New Hope

Sponsors

Collaborators (1)

INC Research Limited

All Listed Sponsors

collaborator

INC Research Limited

INDUSTRY

lead

Replidyne

INDUSTRY

NCT00255983 - A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis | Biotech Hunter | Biotech Hunter